{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:03:25Z","timestamp":1787792605838,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["423987\/2016-0"],"award-info":[{"award-number":["423987\/2016-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/21095-4"],"award-info":[{"award-number":["2011\/21095-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/27841-1"],"award-info":[{"award-number":["2019\/27841-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lfs.2021.120237","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T11:47:07Z","timestamp":1639655227000},"page":"120237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Tadalafil treatment improves cardiac, renal and lower urinary tract dysfunctions in rats with heart failure"],"prefix":"10.1016","volume":"289","author":[{"given":"Aline Goncalves","family":"Mora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Rafael","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina C.","family":"Janussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Tomazini","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Krikorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda B.M.","family":"Priviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Angelo","family":"Claudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120237_bb0005","first-page":"1","article-title":"I Latin American guidelines for the assessment and management of decompensated heart failure","volume":"85","author":"Bocchi","year":"2005"},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ehf2.12021","article-title":"Improving care for patients with acute heart failure: before, during and after hospitalization","volume":"1","author":"Cowie","year":"2014","journal-title":"ESC Heart Fail."},{"issue":"6","key":"10.1016\/j.lfs.2021.120237_bb0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.lfs.2021.120237_bb0020","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ejhf.563","article-title":"New York heart association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy","volume":"19","author":"Braunschweig","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.lfs.2021.120237_bb0030","first-page":"105","article-title":"Coexisting illness and heart disease among elderly medicare managed care enrollees","volume":"25","author":"Bierman","year":"2004","journal-title":"Health Care Financ. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.juro.2009.02.115","article-title":"Urinary incontinence and overactive bladder in patients with heart failure","volume":"182","author":"Palmer","year":"2009","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0040","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ijir.3901426","article-title":"Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem","volume":"17","author":"Rastogi","year":"2005","journal-title":"Int. J. Impot. Res."},{"issue":"4","key":"10.1016\/j.lfs.2021.120237_bb0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1464-410X.2003.04682.x","article-title":"Prevalence of overactive bladder in asian men: an epidemiological survey","volume":"93","author":"Moorthy","year":"2004","journal-title":"BJU Int."},{"issue":"9","key":"10.1016\/j.lfs.2021.120237_bb0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/JU.0000000000001125","volume":"204","author":"Montorsi","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.lfs.2021.120237_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.urology.2020.06.017","article-title":"Optimizing nonsurgical treatments of overactive bladder in the United States","volume":"145","author":"Brucker","year":"2020","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.lfs.2021.120237_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/ggi.12451","article-title":"Effect of pharmacological treatment for urinary incontinence in the elderly and frail elderly: a systematic review","volume":"15","author":"Samuelsson","year":"2015","journal-title":"Geriatr. Gerontol. Int"},{"issue":"10","key":"10.1016\/j.lfs.2021.120237_bb0070","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/j.1743-6109.2009.01416.x","article-title":"Erectile dysfunction in heart failure: correlation with severity, exercise performance, comorbidities, and heart failure treatment","volume":"6","author":"Apostolo","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.lfs.2021.120237_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.lfs.2019.04.017","article-title":"Progression of micturition dysfunction associated with the development of heart failure in rats: model of overactive bladder","volume":"226","author":"Mora","year":"2019","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(97)00038-7","article-title":"Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment","volume":"75","author":"Turner","year":"1997","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjp.0705431","article-title":"NANC inhibitory neurotransmission in mouse isolated stomach: involvement of nitric oxide, ATP and vasoactive intestinal polypeptide","volume":"140","author":"Mul\u00e8","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2021.120237_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2010.04.008","article-title":"Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41\u20132272 in isolated detrusor smooth muscle","volume":"637","author":"B\u00e1u","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cne.20753","article-title":"Functional imaging and the central control of the bladder","volume":"493","author":"Kavia","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.lfs.2021.120237_bb0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/B978-0-12-374247-6.50013-4","article-title":"Central nervous system control of micturition","author":"Holstege","year":"2009","journal-title":"Spinal Cord"},{"issue":"10","key":"10.1016\/j.lfs.2021.120237_bb0105","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1503\/cmaj.060034","article-title":"Current trends in the evaluation and management of female urinary incontinence","volume":"175","author":"Smith","year":"2006","journal-title":"CMAJ"},{"issue":"12","key":"10.1016\/j.lfs.2021.120237_bb0110","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00415-016-8212-2","article-title":"Neurogenic lower urinary tract dysfunction: evaluation and management","volume":"263","author":"Tudor","year":"2016","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.lfs.2021.120237_bb0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.bpobgyn.2005.08.002","article-title":"Overactive bladder","volume":"19","author":"Freeman","year":"2005","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/jsm.12386","article-title":"Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study","volume":"11","author":"Bechara","year":"2014","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0090-4295(02)01686-2","article-title":"Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction","volume":"60","author":"Corbin","year":"2002","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.lfs.2021.120237_bb0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/BF03346679","article-title":"Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation","volume":"33","author":"Comeglio","year":"2010","journal-title":"J. Endocrinol. Investig."},{"issue":"9","key":"10.1016\/j.lfs.2021.120237_bb0140","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.lfs.2021.120237_bb0145","series-title":"Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy","author":"Abassi","year":"2011"},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0150","first-page":"H674","article-title":"Contribution of ventricular remodeling to pathogenesis of heart failure in rats","volume":"280","author":"Brower","year":"2001","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0155","first-page":"33","article-title":"Comparison of the efficacy and safety of 5-mg once-daily versus 5-mg alternate-day tadalafil in men with erectile dysfunction and lower urinary tract symptoms","volume":"27","author":"Choi","year":"2015"},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2015.12.048","article-title":"Latest evidence on the use of phosphodiesterase type 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"70","author":"Gacci","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.lfs.2021.120237_bb0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2015.12.005","article-title":"Erectile dysfunction in heart failure rats is associated with increased neurogenic contractions in cavernous tissue and internal pudendal artery","volume":"145","author":"Rodrigues","year":"2016","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.lfs.2021.120237_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133996","article-title":"Urinary bladder dysfunction in transgenic sickle cell disease mice","volume":"10","author":"Claudino","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lfs.2021.120237_bb0175","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/nau.21074","article-title":"Characterization of the urinary bladder dysfunction in renovascular hypertensive rats","volume":"30","author":"Ramos-Filho","year":"2011","journal-title":"Neurourol. Urodyn."},{"issue":"4","key":"10.1016\/j.lfs.2021.120237_bb0180","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.urology.2009.05.098","article-title":"Upregulation of gp91phox subunit of NAD (P) H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training","volume":"75","author":"Claudino","year":"2010","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.lfs.2021.120237_bb0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/mutage\/gei043","article-title":"Lipoperoxidation products and thiol antioxidants in chromium exposed workers","volume":"20","author":"Goulart","year":"2005","journal-title":"Mutagenesis"},{"issue":"6","key":"10.1016\/j.lfs.2021.120237_bb0190","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jf030723c","article-title":"The chemistry behind antioxidant capacity assays","volume":"53","author":"Huang","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2021.120237_bb0195","article-title":"Health benefits of new symbiotic \u201cNAR\u201d","volume":"2","author":"Saduakhasova","year":"2013","journal-title":"Cent. Asian J. Glob. Health"},{"issue":"5","key":"10.1016\/j.lfs.2021.120237_bb0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/002215540004800502","article-title":"Cellular and subcellular localization of catalase in the heart of transgenic mice","volume":"48","author":"Zhou","year":"2000","journal-title":"J. Histochem. Cytochem."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.120237_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cccn.2004.02.007","article-title":"Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified jaffe method","volume":"344","author":"Junge","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2021.120237_bb0215","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.yjmcc.2014.03.004","article-title":"Nitric oxide synthase regulation of cardiac excitation\u2013contraction coupling in health and disease","volume":"73","author":"Simon","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2021.120237_bb0220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4155\/fmc.13.23","article-title":"Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks?","volume":"5","author":"Bhardwaj","year":"2013","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0225","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004309","article-title":"Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man","volume":"2","author":"Langrish","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.lfs.2021.120237_bb0230","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.cellsig.2008.08.012","article-title":"Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes","volume":"20","author":"Zhang","year":"2008","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0235","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCULATIONAHA.108.822072","article-title":"Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice","volume":"119","author":"Pokreisz","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058841","article-title":"Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling","volume":"8","author":"Vandenwijngaert","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2021.120237_bb0245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10557-014-6559-0","article-title":"Tadalafil prevents acute heart failure with reduced ejection fraction in mice","volume":"28","author":"Salloum","year":"2014","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"8","key":"10.1016\/j.lfs.2021.120237_bb0250","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1242\/dmm.015255","article-title":"TGF-\u03b2 mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve disease","volume":"7","author":"Munjal","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0255","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000431260","article-title":"Pharmacological modulation of mucosa-related impairment of \u03b2-adrenoceptor-mediated relaxation in human detrusor","volume":"95","author":"Propping","year":"2015","journal-title":"Urol. Int."},{"issue":"5","key":"10.1016\/j.lfs.2021.120237_bb0260","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/nau.21108","article-title":"Rodent models for urodynamic investigation","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53136-y","article-title":"Tadalafil treatment improves inflammation, cognitive function, and mismatch negativity of patients with low urinary tract symptoms and erectile dysfunction","volume":"9","author":"Urios","year":"2019","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.lfs.2021.120237_bb0270","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/pros.22686","article-title":"PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS","volume":"73","author":"Vignozzi","year":"2013","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1743-6109.2009.01558.x","article-title":"Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats","volume":"7","author":"Morelli","year":"2010","journal-title":"J. Sex. Med."},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0280","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lfs.2007.05.004","article-title":"Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract","volume":"81","author":"Yono","year":"2007","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2021.120237_bb0285","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.urology.2005.08.014","article-title":"Non-neuronal cholinergic system in human bladder urothelium","volume":"67","author":"Yoshida","year":"2006","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.lfs.2021.120237_bb0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrurol.2014.53","article-title":"Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH\u2013LUTS","volume":"11","author":"Cellek","year":"2014","journal-title":"Nat. Rev. Urol."},{"issue":"5","key":"10.1016\/j.lfs.2021.120237_bb0295","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0300","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2021.120237_bb0305","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1476-5381.2011.01311.x","article-title":"Functional, morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice: evidence of a role for L-type voltage-operated Ca2+ channels","volume":"163","author":"Leiria","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2021.120237_bb0310","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1464-410X.2009.08651.x","article-title":"Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder","volume":"104","author":"Werkstr\u00f6m","year":"2009","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.lfs.2021.120237_bb0315","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.juro.2007.07.048","article-title":"Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study","volume":"178","author":"Gacci","year":"2007","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.lfs.2021.120237_bb0320","first-page":"3","article-title":"III Diretriz brasileira de insufici\u00eancia card\u00edaca cr\u00f4nica","volume":"93","author":"Bocchi","year":"2009","journal-title":"Arq. Bras. Cardiol."},{"issue":"7","key":"10.1016\/j.lfs.2021.120237_bb0325","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.lfs.2021.120237_bb0330","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.kjms.2015.06.005","article-title":"The protective effects of tadalafil on renal damage following ischemia reperfusion injury in rats","volume":"31","author":"Erol","year":"2015","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2021.120237_bb0335","doi-asserted-by":"crossref","first-page":"F1099","DOI":"10.1152\/ajprenal.00649.2012","article-title":"Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1","volume":"304","author":"Sohotnik","year":"2013","journal-title":"Am. J. Physiol.Renal Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120237_bb0340","first-page":"6274","article-title":"Tadalafil for prevention of renal dysfunction secondary to renal ischemia","volume":"19","author":"Faddegon","year":"2012","journal-title":"Can. J. Urol."},{"key":"10.1016\/j.lfs.2021.120237_bb0345","series-title":"Allopurinol protects against ischemia\/reperfusion-induced injury in rat urinary bladders","author":"Shin","year":"2015"},{"key":"10.1016\/j.lfs.2021.120237_bb0350","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ejphar.2015.09.015","article-title":"Cardioprotective role of tadalafil against cisplatin-induced cardiovascular damage in rats","volume":"765","author":"Saleh","year":"2015","journal-title":"Eur. J. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521012248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521012248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:44:42Z","timestamp":1777423482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521012248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":69,"alternative-id":["S0024320521012248"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120237","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tadalafil treatment improves cardiac, renal and lower urinary tract dysfunctions in rats with heart failure","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120237"}}